Benzoazepin-oxy-acetic acid derivatives as PPAR-delta agonists used for the increase of HDL-C, lower LDL-C and lower cholesterol

Details for Australian Patent Application No. 2007237928 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Demarest, Keith T.; Zhang, Yan; Lu, Songfeng; Shen, Lan; Pelton, Patricia; Gee-Hong, Kuo

Agent Shelston IP

Pub. Number AU-B-2007237928

PCT Pub. Number WO2007/121432

Priority 60/793,001 18.04.06 US

Filing date 17 April 2007

Wipo publication date 25 October 2007

Acceptance publication date 14 June 2012

International Classifications

A61P 1/18 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 223/16 (2006.01) Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom

Event Publications

6 November 2008 PCT application entered the National Phase

  PCT publication WO2007/121432 Priority application(s): WO2007/121432

17 November 2011 Application Accepted

  Published as AU-B-2007237928

14 June 2012 Application Accepted

  Published as AU-B-2007237928

11 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007237929-Dual purpose card reader

2007237923-Electricity generating apparatus utilizing a single magnetic flux path